Plain-English translation of NCT05390424 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hepatitis B research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a new, easier way to screen for three serious viruses—hepatitis B, hepatitis C, and HIV—using a small dried blood spot collected from a finger prick instead of a traditional blood draw. Researchers want to see if this simple method works well for screening people who have used intravenous or nasal drugs, including those currently on medication-assisted treatment for opioid addiction. This approach could make testing faster, less intimidating, and more accessible.
Many people who use drugs face barriers to getting tested for serious infections, including fear of needles or lack of access to healthcare. A simpler, less invasive testing method could help more people get screened early, when treatment is most effective.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would have a small blood sample collected using a finger prick—similar to a glucose test—which is then dried on a special card. This simple procedure takes just a few minutes, and your sample will be tested for the three viruses. The study is recruiting about 500 people and is based at University Hospital in Rouen, France.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France